Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Valsartan Prices, Demand and Supply Overview
Valsartan prices in Germany, the highest-cost reporting region, rose 6.0% in H1 2026, climbing from USD 61.2/KG in Q1 to USD 64.9/KG by Q2 as firmer tetrazole synthesis intermediate costs and recovering antihypertensive, heart failure, and diabetic nephropathy treatment formulation procurement reversed the brief Q4 2025 market correction. Globally, the average rose from USD 43.26/KG in Q1 to USD 45.86/KG in Q2, a 6.0% gain. For H2 2026, a global average of USD 46.50-51.80/KG is expected, with continued firming on Middle East supply disruptions and growing antihypertensive and cardiovascular protection sector demand globally.
Valsartan is a non-peptide angiotensin II receptor antagonist of the sartan class produced by multi-step synthesis from L-valine-derived chiral precursors through N-acylation, tetrazole ring formation via cycloaddition of a tributyltin azide or sodium azide reagent onto a nitrile intermediate under controlled conditions, and biphenyl methyl group introduction to yield the N-valeryl-N-[[2’-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]valine active pharmaceutical ingredient. The compound selectively blocks the angiotensin II type 1 receptor, preventing angiotensin II-mediated vasoconstriction, aldosterone secretion, renal sodium reabsorption, and cardiac and vascular remodelling to lower blood pressure and reduce cardiac afterload without the reflex tachycardia associated with direct vasodilators. The largest pull comes from first-line and combination antihypertensive prescribing, supported by its well-established tolerability, absence of the ACE inhibitor dry cough, and once-daily dosing convenience across adult hypertensive populations globally. Heart failure hospitalisation and mortality reduction, post-myocardial infarction cardiac protection, and diabetic nephropathy progression slowing add further significant demand. Combination formulations with amlodipine and hydrochlorothiazide for multifactorial antihypertensive management add a growing fixed-dose segment. Tetrazole synthesis intermediate costs, antihypertensive prescription volumes, and regional API production capacity all feed into the price.
Valsartan Price Forecast for 2026
The balance of supply and demand for valsartan through H2 2026 leans moderately firm. Tetrazole and valine synthesis intermediate costs firmed from Middle East and supply chain disruptions. Antihypertensive prescribing volumes are growing with expanding hypertension awareness programmes, ageing demographics, and growing cardiovascular risk factor management in emerging markets.
The main upside risk is synthesis intermediate cost increases alongside accelerating cardiovascular disease management demand. The main downside risk is continued Chinese API surplus and generic competition limiting the global price recovery below forecast.
| Region | Price Forecast (USD/KG) | Key Driver |
| Global Average | 46.50 - 51.80 | Synthesis cost firming and antihypertensive/cardiovascular demand |
| United States | 49.60 - 54.90 | Steady antihypertensive and heart failure demand holds firm |
| China | 33.50 - 38.80 | Large API capacity keeps it the most affordable |
| Germany | 65.50 - 70.80 | High synthesis and energy costs keep it the most expensive |
| India | 47.30 - 52.60 | Growing antihypertensive and export Rx demand holds a firm middle |
For the Quarter Ending June 2026
Valsartan Prices Q2 2026:
- United States: USD 53.0/KG
- China: USD 37.0/KG
- Germany: USD 64.9/KG
- India: USD 50.5/KG
Valsartan Prices in the United States
US Valsartan prices averaged USD 53.0/KG in Q2 2026, up 6.0% from USD 50.0/KG in Q1 2026. Firmer synthesis intermediate costs and recovering antihypertensive and heart failure treatment procurement drove consistent buying through the quarter.
Why did the price of Valsartan change in Q2 2026 in the United States?
Firmer tetrazole and valine synthesis intermediate costs raised the API production floor. Antihypertensive, heart failure, and diabetic nephropathy formulation procurement lifted buying. Post-MI cardiac protection prescribing provided additional buying support near USD 53.0/KG.
Valsartan Prices in China
Chinese Valsartan prices averaged USD 37.0/KG in Q2 2026, up 6.0% from USD 34.9/KG in Q1 2026, the lowest among the tracked markets. Spring antihypertensive export and domestic cardiovascular procurement lifted buying. Firmer domestic synthesis costs raised the production floor despite domestic API capacity.
Why did the price of Valsartan change in Q2 2026 in China?
Spring antihypertensive and cardiovascular export and domestic procurement lifted buying. Firmer domestic tetrazole synthesis costs raised the production floor. Domestic API capacity kept China the most affordable source.
Valsartan Prices in Germany
German Valsartan prices averaged USD 64.9/KG in Q2 2026, up 6.0% from USD 61.2/KG in Q1 2026, the highest among the tracked markets. Higher tetrazole synthesis intermediate and energy costs elevated European API production economics. Consistent antihypertensive, heart failure, and diabetic nephropathy procurement maintained consistent buying.
Why did the price of Valsartan change in Q2 2026 in Germany?
Higher tetrazole synthesis intermediate and energy costs elevated European API production economics. Middle East supply disruptions added cost premiums to synthesis substrate supply chains. Consistent antihypertensive and cardiovascular protection procurement maintained buying near USD 64.9/KG.
Valsartan Prices in India
Indian Valsartan prices averaged USD 50.5/KG in Q2 2026, up 6.1% from USD 47.6/KG in Q1 2026. Growing antihypertensive, heart failure, and export demand supported buying. Firmer synthesis import costs raised the production floor through the quarter.
Why did the price of Valsartan change in Q2 2026 in India?
Growing antihypertensive and cardiovascular export and domestic procurement lifted buying. Firmer tetrazole synthesis import costs raised the production floor. Post-MI and diabetic nephropathy export demand provided additional buying support near USD 50.5/KG.
For the Quarter Ending March 2026
Valsartan Prices Q1 2026:
- United States: USD 50.0/KG
- China: USD 34.9/KG
- Germany: USD 61.2/KG
- India: USD 47.6/KG
Valsartan Prices in the United States
US Valsartan prices averaged USD 50.0/KG in Q1 2026, recovering about 2.0% from Q4 2025. Recovering antihypertensive and heart failure demand and firming synthesis costs held the market near USD 50.0/KG.
Why did the price of Valsartan change in Q1 2026 in the United States?
Recovering antihypertensive and heart failure formulation procurement maintained buying. Firming tetrazole synthesis intermediate costs raised the production floor. The market recovered to USD 50.0/KG from the Q4 2025 correction.
Valsartan Prices in China
Chinese prices averaged USD 34.9/KG in Q1 2026, recovering about 1.7% from Q4 2025. Post-Lunar New Year antihypertensive export restocking and firming synthesis costs held the market near USD 34.9/KG.
Why did the price of Valsartan change in Q1 2026 in China?
Post-Lunar New Year antihypertensive export and domestic restocking lifted buying. Firming domestic tetrazole synthesis costs raised the production floor. The market recovered to USD 34.9/KG from the Q4 2025 correction.
Valsartan Prices in Germany
German prices averaged USD 61.2/KG in Q1 2026, recovering about 2.0% from Q4 2025. Recovering antihypertensive and cardiovascular demand and firming synthesis and energy costs held the market near USD 61.2/KG.
Why did the price of Valsartan change in Q1 2026 in Germany?
Recovering antihypertensive and heart failure procurement maintained buying. Firming tetrazole synthesis and energy costs held the production floor. The market recovered to USD 61.2/KG from the Q4 2025 correction.
Valsartan Prices in India
Indian prices averaged USD 47.6/KG in Q1 2026, recovering about 1.9% from Q4 2025. Growing antihypertensive export and domestic demand and firming import costs held the market near USD 47.6/KG.
Why did the price of Valsartan change in Q1 2026 in India?
Growing antihypertensive and cardiovascular export and domestic procurement maintained buying. Firming tetrazole synthesis import costs raised the production floor. The market recovered to USD 47.6/KG from the Q4 2025 correction.
Quarterly Valsartan Price Trends
Global Valsartan prices rose in Q3 2025 on the antihypertensive season, dipped in Q4 2025 on synthesis feedstock moderation, then recovered through Q1 and Q2 2026. The average rose from USD 42.0/KG in Q2 2025 to USD 42.84/KG in Q3, eased to USD 42.41/KG in Q4, then firmed to USD 43.26/KG in Q1 2026 and USD 45.86/KG in Q2 2026, a net gain of about 9.2% over the window. Tetrazole synthesis intermediate cost cycles and antihypertensive and cardiovascular treatment demand drove the overall pattern.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 45.86 | +6.0% | ↑ Rising |
| Q1 2026 | 43.26 | +2.0% | ↑ Rising |
| Q4 2025 | 42.41 | -1.0% | ↓ Falling |
| Q3 2025 | 42.84 | +2.0% | ↑ Rising |
| Q2 2025 | 42.0 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
What was Valsartan Price in 2025?
Valsartan prices firmed modestly through 2025 on consistent antihypertensive and cardiovascular demand. The global average opened near USD 42.0/KG in Q1 2025 and closed at USD 42.41/KG in Q4, a marginal full-year gain of about 1.0%. Consistent tetrazole synthesis cost dynamics and antihypertensive prescribing volumes drove the quarterly pattern throughout the year.
Valsartan Prices in the United States in 2025
US prices firmed from about USD 48.5/KG in Q1 2025 to USD 49.0/KG by Q4, a gain of 1.0%. Consistent antihypertensive and heart failure demand maintained the modest upward trend through the year.
Valsartan Prices in China in 2025
Chinese prices firmed from roughly USD 33.8/KG in Q1 2025 to USD 34.2/KG by Q4, a gain of 1.2%. Growing antihypertensive export and domestic cardiovascular demand drove modest firming despite domestic API capacity.
Valsartan Prices in Germany in 2025
German prices firmed from about USD 59.5/KG in Q1 2025 to USD 60.0/KG by Q4, a gain of 0.8%. Consistent antihypertensive, heart failure, and diabetic nephropathy demand and firm synthesis costs supported.
Valsartan Prices in India in 2025
Indian prices firmed from roughly USD 46.2/KG in Q1 2025 to USD 46.7/KG by Q4, a gain of 1.1%. Growing antihypertensive export and domestic cardiovascular treatment demand drove modest firming.
How We Can Help
Expert Market Research: Your Source for Real-Time Valsartan Price Intelligence
Expert Market Research tracks Valsartan prices continuously across every major producing and consuming region. The team traces causation through tetrazole and valine synthesis intermediate economics, antihypertensive and cardiovascular treatment procurement cycles, and regional API production capacity. Contact Expert Market Research today for Valsartan pricing data, bespoke market analysis, and strategic procurement advisory.
Pricing Plans
Upto 15% Off
USD
-
$799 $699
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Key Questions Answered in the Report
First-line and step-up antihypertensive prescribing takes the largest share, supported by its well-established tolerability, absence of the ACE inhibitor cough, and once-daily dosing convenience. Heart failure hospitalisation and mortality reduction, post-myocardial infarction cardiac protection, and diabetic nephropathy progression reduction also consume significant volumes globally.
The Q2 2026 average was USD 53.0/KG in the United States, USD 37.0/KG in China, USD 64.9/KG in Germany, and USD 50.5/KG in India. Germany remains the highest-priced market.
The global average rose from USD 43.26/KG in Q1 to about USD 45.86/KG in Q2, a gain of around 6.0%. Recovering antihypertensive and cardiovascular demand and firmer tetrazole synthesis costs drove the H1 firming from the Q4 2025 correction.
Tetrazole synthesis intermediate cost moderation eased the API production floor. Seasonal antihypertensive and heart failure formulation procurement moderation reduced buying urgency before the H1 2026 recovery.
The global average is expected in the USD 46.50 to 51.80/KG range for H2 2026, with continued firming as synthesis costs stay elevated and antihypertensive and cardiovascular protection demand grows.
Germany sits highest on synthesis and energy costs, the United States and India hold a firm middle on antihypertensive and cardiovascular demand, and China prices lowest on domestic API capacity.
This report is updated monthly. For real-time pricing intelligence, contact the Expert Market Research team directly.
Prices respond mainly to tetrazole and valine synthesis intermediate costs, antihypertensive prescribing volume cycles, and cardiovascular disease management guideline changes. Ageing population demographics and hypertension treatment access expansion are key demand signals.
China and India hold the largest valsartan API synthesis capacity. Any tetrazole synthesis intermediate cost shift ripples across markets within one to two quarters.
Buyers can use quarterly trends and forecasts to time antihypertensive formulation contracts around synthesis cost cycles, build cover when tetrazole signals tighten, and monitor cardiovascular prescribing volume data as the primary demand signal.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
- Report in Excel Format
- 3 Months Price Forecast
- Historical Prices for the Past 3 Years
-
Summary Of Factors Influencing Prices
- Current Price Overview
- 3-Month Price Forecast
- Historical Price Summary
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.